AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
ORLANDO, FLA. -- Permanent contraception may one day be available without surgery.
A new technique known as the selective tubal occlusion procedure (STOP) involves the use of an experimental device that is implanted within the fallopian tubes during hysteroscopy. The office-based procedure was found to be safe and effective in phase II trials, and a phase III trial is now underway, Dr. Jay M. Cooper said at the annual meeting of the American Association of Gynecologic Laparoscopists.
It is expected that the trial will be completed and the data sent to the Food and Drug Administration for review early next year, said Dr. Cooper, a paid consultant to Conceptus Inc., the device manufacturer.
To date, more than 200 women have received STOP devices. In the phase II trial, 70 women were followed for at least 12 months. All of these women rated their experience with the device as excellent or very good, and in more than 1,600 women-months of use, no pregnancies have been reported, said Dr. Cooper, who is founder and medical director of Women's Health Research in Phoenix, Ariz. "There have been no complaints of pain or bleeding necessitating removal of the device," he added.
Source: HighBeam Research, Nonsurgical Approach to Permanent Contraception Investigated.